Novavax (NVAX) Misses Q3 EPS by 40c
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $8.94 +6.18%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($4.31), $0.40 worse than the analyst estimate of ($3.91). Revenue for the quarter came in at $178.8 million versus the consensus estimate of $334.62 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Is the global equity rally broadening? UBS weighs in
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
